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There  is  now  considerable evidence to  indicate that  heterogeneity exists 
among thymus-independent (B) lymphocytes (1-4). One particularly important 
model in which to analyze the functions of B-lymphocyte subpopulations has 
been provided by the CBA/N  strain of mice which has an X-linked immune 
defect  (5-8).  Extensive  studies  of this  strain  and  of F~  hybrids  which are 
hemizygous for the  CBA/N  X  chromosome suggest that the  immune defect 
reflects a maturational arrest, with a consequent deficit in or absence of a late 
developing B-lymphocyte  subpopulation (2, 9-12). We reasoned that the absence 
of this  subpopulation  of cells from  CBA/N  mice  should  make possible  the 
development of alloantisera specific for a differentiation antigen (or antigens) 
unique to these late developing B cells. Such sera would have obvious value for 
the delineation of functions and characteristics of B-lymphocyte subpopulations 
from normal strains. 
In this communication  we describe a cytotoxic alloantiserum which recognizes 
a B-cell differentiation antigen. This serum was produced by immunization of 
C57BL/6 mice with DBA/2 spleen cells and was made specific by absorption with 
thymus and spleen cells derived from (CBA/N  ~  ×  DBA/2  d)Fl male mice, 
which are hemizygous for the defective X chromosome and which display the 
immune defect. We show that the serum interacts with a  subclass of B cells 
characterized by: (a) a late appearance in ontogeny, (b) the possession of the 
complement receptor, (c) a relatively low ratio of surface IgM to surface IgD, 
and (d) low-to-intermediate amounts of tetal surface Ig. 
* This work was supported in part by the Naval Medical Research and Development Command, 
Work  Unit Nos. MF51.524.013.1001,  MR041.02.01.0020,  and MR000.01.01.1129.  The opinions or 
assertions contained herein are the private ones of the authors and are not to be construed as 
official or reflecting the views of the U. S. Navy Department or the naval service at large. The 
experiments reported herein were conducted according to the principles set forth in the "Guide for 
the Care and Use of Laboratory Animals," Institute of Laboratory Animal Resources, National 
Research Council, DHEW publication no. (NIH) 74-23. 
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Materials and Methods 
Mice.  DBA/2N, CBA/N, C57BL/6N,  and (CBA/N  ~  x  DBA/2  c~)F, mice were obtained from 
the Division of Research Services of the National Institutes of Health, Bethesda, Md. Adult mice 
of 8-12 wk of age were used in these experiments. They were killed by cervical dislocation. 
Immunization Procedures.  Adult male C57BL/6 mice were immunized with 50 x  10  e DBA/2 
spleen cells emulsified in complete Freund's adjuvant (final vol 0.2 ml) by footpad injection. They 
were boosted by intraperitoneal inoculation with 25 ×  106 DBA/2 spleen cells in media at weekly 
intervals thereafter, for a total of 4 wk. Sera were collected 4 days after the last boost. 
Cytotoxicity Assay.  A trypan blue exclusion microcytotoxicity technique described previously 
was used in this study (13).  RPMI 1640  (Grand Island Biological Co., Grand Island, N. Y.) was 
used as media. Doubling dilutions of antiserum or normal C57BL/6 serum (50 ~l; ultracentrifuged 
at 100,000g for 40 min before their use) were added to 104 spleen cells (50 ~1). The cell suspension 
was incubated at 4°C for 30 min and then washed twice.  100 ~1 of a  1:8 dilution of rabbit serum, 
which had been absorbed with mouse liver powder, was added as a source of complement (C). The 
cells were incubated at 37°C for 30 min, and the percent cytotoxicity was judged by scoring 200 cells 
after adding 50 ~1 of a  0.4% solution of trypan blue. 
The chromium release assay was performed as described previously (7). 5~Cr was supplied as 
Na~CrO4 (Amersham/Searle Corp., Arlington Heights, Ill.). Assays were done in triplicate and 
the net specific ~lCr +_ SE was determined by the following formula: 
% net chromium released 
= radioactivity released by antisera and C  -  radioactivity released by NMS and C 
x I00 
radioactivity released by freeze-thawing -  radioactivity released by NMS and C 
Absorption Procedures.  2 x  109 (CBA/N Q ×  DBA/2 d)F, male thymocytes were used to absorb 
1 ml of heat-inactivated (56°C,  30 min) C57BL/6 anti-DBA/2 antiserum by slowly rotating the 
resultant cell suspension at 4°C for 1 h. After removal of the thymocytes by centrifugation, F, male 
spleen cells, in increments of 0.5 ×  10  ~, were used for absorption until the antiserum was no longer 
cytotoxic for F, male spleen cells. This generally required a total of 2 ×  109 F, male spleen cells in 
addition to the initial absorption with 2  ×  109 F, male thymocytes. 
Isolation of B Lymphocytes with the Fluorescence-Activated Cell Sorter.  A  fluorescein-conju- 
gated  F(ab')2  goat  anti-mouse  Ig  (F1  anti-Ig)' was  used  to  stain mouse  spleen cells  as  noted 
previously (2). The Fluorescence-activated cell sorter (FACS; Becton-Dickinson Electronics Labo- 
ratory, Mountain View, Calif.) was used to separate Ig-negative (Ig-) cells (channels 0-80) from 
Ig-positive  (Ig  ÷) cells  (channels 80-1,000)  (Fig.  1).  In addition,  Ig  + cells with a  relatively low 
density of surface Ig (channels 80-420) were separated from Ig  ÷ cells with a relatively high density 
of surface Ig (channels 420-1,000). 
Separation of Complement Receptor Lymphocytes.  Ig  + spleen cell suspensions (5  x  10~/ml), 
obtained from the FACS, were mixed with an equal vol (0.4 ml) of sheep erythrocytes coated with 
anti-Forssman antibody and complement (EAC) reagent (14) for 45 min at 37°C. The mixture was 
then layered on Ficoll-Hypaque (specific grade 1.094) and centrifuged for 30 min at 450g. The cells 
at the interface were collected, washed, and an aliquot was incubated with EAC to determine the 
frequency of complement receptor (CR) lymphocytes. Since less than 3% of these cells were CR  ÷, 
this population was considered to be enriched in CR- Ig  ÷ lymphocytes. The cells in the pellet were 
treated  to remove erythrocytes  (2),  washed with media,  and regarded as a  source of CR  ÷ Ig  ÷ 
lymphocytes. 
Analysis of Lymphocyte Surface Immunoglobulin  Class.  Spleen cell surface molecules were 
labeled with  '2~I (1.5 mCi '~51/10 ×  106 cells in  1 ml of phosphate-buffered saline  [Amersham/ 
Searle]) using the lactoperoxidase catalyzed procedure for radioiodination as previously described 
(9). Cells were lysed with Nonidet P-40 (0.5% in phosphate-buffered saline) and immunoglobulin 
precipitated with a goat anti-mouse immunoglobulin (Meloy Laboratories, Springfield, Va.) and a 
Staphylococcus aureus  of the  Cowan I  strain (15).  '2'~I-labelod Ig was solubilized,  reduced,  and 
' Abbreviations used in this paper: CR, complement receptor; EAC, sheep erythrocytes coated 
with anti-Forssman antibody and complement; FACS,  fluorescence-activated cell sorter; LAD, 
lymphocyte-activating determinant;  Mls,  minor  lymphocyte  stimulating  locus;  NMS,  normal 
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FIG.  1.  The fluorescence profile of adult DBA/2 spleen ceils stained with a fluorescein- 
conjugated  F(ab')2  goat  anti-mouse  Ig.  Separation  of cells  into  Ig-  (channels  0-80),  Ig  + 
(channels 80-1,000),  low-t~-intermediate density surface  Ig  + (channels 80-420),  and high 
density of surface Ig  + (channels 420-1,000)  are noted. The fluorescence intensity of lympho- 
cytes is plotted on the x axis (channels 0-1,000),  and the number of cells at each intensity is 
plotted on the y axis. 
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analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis as previously described (9). 
Each electrophoretic profile represents 10  x  106 cpm ~25I of solubilized cell-surface molecules. 
Results 
Cytotoxicity  of C57BL/6  Anti-DBA/2  Antiserum.  In  an  effort  to  isolate 
alloantibodies directed at differentiation antigens expressed by B lymphocytes 
absent from (or present in reduced numbers in) mice with the CBA/N immune 
defect,  C57BL/6  anti-DBA/2  sera  were  extensively  absorbed with lymphoid 
cells from phenotypically abnormal (CBA/N  Q ×  DBA/2 c~)Fl male mice. 1 ml 
of antiserum was absorbed with a total of 2 x  109 F1 male thymocytes, as noted 
in the Materials and Methods section. This preparation remained cytotoxic for 
100% of F1 male, female, and DBA/2 spleen cells (Table I). Continued absorp- 
tion with increasing numbers of F1 male spleen cells reduced the cytotoxicity of 
the antiserum for F1 male cells to less than 6% while the serum continued to 
lyse approximately 26% of F1 female and DBA/2 spleen cells. 
In separate  experiments,  the  titers  at which the  absorbed antiserum re- 
mained  cytotoxic  for  DBA/2  and  F1  female  cells  were  determined  both by 
trypan blue exclusion and by 5~Cr-release  assays.  As shown in Fig.  2,  a  1:4 
dilution of antiserum resulted in a net cytotoxicity, by trypan blue exclusion, 
of 25.3%  for FI female cells  and 18.2% for DBA/2  cells;  similar results were 
obtained with a 1:8 dilution. In a series of trypan blue exclusion experiments, 
conducted  with  different  preparations  of the  absorbed  antiserum,  the  net 104  B-LYMPHOCYTE  HETEROGENEITY 
TABLE I 
Cytotoxicity  of C57BL/6 Anti-DBA/2 Antisera* 
Number of F1 male 
cells used for absorp- 
tion 
Source 
Net percent spleen cell cytotoxicity$ 
F1  ~  F,  ~  DBA/2 
-  -  >95  >95  >95 
2  x  109  Thymocytes  >95  >95  >95 
0.5  x  109  Spleen  >95  >95  >95 
1.0  x  109  Spleen  46.2  >95  >95 
1.5  x  109  Spleen  12.5  73.9  62.5 
2.0  x  109  Spleen  <6  39.5  44.5 
3.0  x  109  Spleen  <6  38.2  29.2 
4.0  x  109  Spleen  <6  34.5  26.8 
* 1 ml of antisera was absorbed with the indicated number of F,  male cells. Cytotoxicity was 
measured by the trypan blue dye exclusion technique. 
$ The maximum percent cytotoxicity caused by a dilution (1:2-1:32)  of the absorbed C57BL/6  anti- 
DBA/2 antiserum minus the maximum percent cytotoxicity caused by a  dilution (1:2-1:32)  of 
NMS. The percent cytotoxicity of the NMS, complement control ranged from 6.0 to 7.9. 
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RECIPROCAL  OF  ABSORBED  C57BL/6  ANTI-DBA/2  ANTISERUM  DILUTION 
Fro.  2.  Cytotoxicity titer of C57BL/6  anti-DBA/2 absorbed serum for spleen cells from 
CBA/N female, DBA/2 female, and (CBA/N  9  x  DBA/2  d)F1 male and F, female mice as 
measured by the trypan blue dye exclusion technique. 
maximum  percent cytotoxicity for F 1 female and  DBA/2 spleen cells ranged 
from 23.7 to 31.6% and from 18.2 to 36.0%, respectively. Using a  5'Cr-release 
assay, comparable results were obtained (Fig. 3). 
Analysis of Cell Type Lysed  by Absorbed Antisera.  The  absorbed serum 
appeared to identify an alloantigen present on spleen cells of phenotypically 45  f 
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RECIPROCAL  OF  ABSORBED  C57BL/6  ANTI-DBA/2  ANTISERUM  DILUTION 
Fro. 3.  Cytotoxicity  titer of C57BL16 anti-DBA/2 absorbed serum for spleen cells from 
CBA/N female, DBA/2 female, and (CBA/N ?  × DBA/2 8)F1 male and F1 female mice as 
measured by the 51Cr-release assay. 
normal F1 female mice and absent (or markedly diminished) on spleen cells of 
immunologically  defective F1 male mice. Since the FI male mice appear to lack 
a  mature or  late developing population of B  lymphocytes, we attempted to 
determine whether this cell population in immunologically normal mice bore 
the alloantigen recognized by the absorbed antiserum. Initially, we incubated 
spleen cells of adult F1 male, F1 female, and C57BL/6 mice with F1 anti-Ig and 
separated  fluorescence positive  cells  (Ig  ÷)  from fluorescence negative  cells 
(Ig-) with the FACS (Fig. 1). When adult F1 male spleen cells were separated 
in this manner, 6.0%  or fewer of Ig  ÷ or Ig- cells were lysed by the absorbed 
antiserum and C  (Table II). Similarly, only 7.4%  of Ig- cells from F~ female 
animals were lysed. By contrast, the percentage of cells lysed by the absorbed 
antiserum was increased considerably when Ig  ÷ F1 female spleen cells were 
compared  to  unsorted  F1  female  spleen  cells  (59.8  vs.  31.6%) (Table  II). 
Further  separation  of adult  Ig  ÷  F~  female  spleen  cells  into  CR  +  and  CR- 
populations resulted in an Ig  + CR  ÷ population that was very susceptible to 
lysis (75.8%)  and an Ig  + CR- population that was not (5.3%).  As anticipated 
from the fact that the  serum was prepared  in C57BL/6 mice,  it showed no 
cytotoxicity for C57BL/6 spleen cells. 
Scher  et al.  previously demonstrated that Ig  + cells which bear a  low-to- 106  B-LYMPHOCYTE  HETEROGENEITY 
TABLE  II 
Cytotoxicity of Absorbed Antisera for FACS-Separated Spleen Cells* 
Net percent cytotoxicity$ 
Strain  Ig+§ 
Unsorted  Ig-  Ig  + 
CR-  CR  + 
C57BL/6  0.0  0.0  0.0  -  - 
(CBA/N  ~  x  DBA/N d)F, d  3.5  6.0  4.5  8.8  7.4 
(CBA/N  ~  x  DBA/N d)F,  ?  31.6  7.4  59.8  5.3  75.8 
* Cytotoxicity was measured by the trypan blue dye exclusion technique. 
The maximum percent cytotoxicity caused by a dilution (1:2-1:32) of the absorbed C57BL/6  anti- 
DBA/2 antiserum minus the maximum percent cytotoxicity caused by a  dilution (1:2-1:32)  of 
NMS. Cells were labeled with F1 anti-Ig and passed through the FACS before treatment with the 
absorbed antisera. Ig  ÷ and Ig- cells were separated using the FACS. 
§ Ig  + Cr- and Ig  ÷ Cr  ÷ cells were isolated as described in the Materials and Methods section. 
intermediate density of surface Ig are relatively deficient in adult CBA/N and 
F1 male mice (10). To determine if the B-lymphocyte antigen detected by the 
absorbed antiserum was associated with this subpopulation of B lymphocytes, 
F1 female spleen cells were separated into those bearing low-to-intermediate 
from those bearing high densities of surface Ig by sorting with the FACS (Fig. 
1).  Among lymphocytes bearing a  low-to-intermediate density of surface Ig, 
81.2% were lysed by the absorbed antiserum, while cells bearing a high density 
of surface Ig were only lysed to an extent of 21.2%. Thus, the majority of cells 
with a low-to-intermediate density of surface Ig possess the alloantigen. 
Ratio of Surface IgM to IgD in F~ Female Cells After Killing with Absorbed 
Antisera.  Splenic B lymphocytes of neonatal mice and those of adult CBA/N 
and adult (CBA/N $  x DBA/2  d)F~ male mice have been shown to have a high 
ratio of surface IgM to the putative mouse homolog of human IgD (hereafter 
referred to as IgD) when compared to splenic B lymphocytes of normal adult 
mice (9, 16). To examine the ratio of surface IgM to IgD on those B lymphocytes 
of F~ females which were not susceptible to lysis by the absorbed antiserum, we 
treated F~ female spleen cells with the absorbed antiserum and C. Live cells 
were recovered by Ficoll-Hypaque centrifugation, labeled with '25I using the 
lactoperoxidase technique, solubilized with 0.5% NP-40 in phosphate-buffered 
saline, and the surface Ig precipitated as noted in the Materials and Methods 
section. Fig. 4 illustrates the sodium dodecyl sulfate-polyacrylamide  gel elec- 
tropherogram of l~SI-labeled membrane immunoglobulin obtained  from  F1 
female spleen cells treated with normal mouse serum (NMS) and C (Fig.  4 B) 
or with absorbed antiserum and C (Fig. 4 A). The ratio of surface IgM to IgD in 
the NMS- and C-treated cells is approximately one, as has been demonstrated 
previously when the spleens of adult mice are examined (9,  16). By contrast, 
the cells that remained after lysis with the absorbed antiserum and C had a 
very high ratio of surface IgM to IgD. 
Ontogeny  of Alloantigen-Bearing  B Lymphocytes  in DBA/2 Mice.  The re- 
sults  presented thus far indicate that  the alloantigen(s) recognized in  the 
absorbed antiserum is present on a subpopulation of B lymphocytes deficient 
or absent in immune defective CBA/N and F~ male mice. Previous studies have I-I 
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Fro.  l.  SDS-polyac~flarnide  gel electropherogTam of '25I-labeled membrane immunoglob- 
ulin specifically  precipitated from (CBA/N 2 x DBA/2 ~)F, female spleen cells pretreated 
with (A) absorbed C57BL/6 anti-DBA/2 serum + C. (B) NMS + C. 
indicated  that  this  subpopulatpon  develops relatively  late  in  the  course  of 
maturation  in  normal  mice.  Consequently,  we  examined  the  ontogeny  of 
alloantigen-bearing cells in DBA/2N mice, an immunologically normal strain. 
Among spleen  cells of 14-day-old DBA/2 mice,  only 5.7% were lysed by the 
absorbed antiserum,  in contrast to the lysis of 34.5% of adult (>8 wk) spleen 
cells by this  serum  (Table III).  Furthermore,  with FACS-purified cells only 
20.6%  of Ig  +  spleen  cells  derived  from  14-day-old  DBA/2  mice  were  lysed, 
whereas 66.7% of adult Ig  + cells were lysed. This indicates that the increase 
during  maturation  of cells  capable  of being  lysed  by the  absorbed  serum 
represents  expansion  of a  subpopulation  of Ig  + lymphocytes bearing  the  al- 
loantigen  and  provides further  evidence  that  the  differentiation  antigen  is 
expressed on a  mature subpopulation of B lymphocytes. 
Discussion 
Previous work in our laboratory has demonstrated that CBA/N mice and F, 
male mice derived from crosses of CBA/N female mice with normal male mice 108  B-LYMPHOCYTE  HETEROGENEITY 
TABLE  III 
Cytotoxicity of Absorbed Antisera  of FACS-Separated DBA/2 Spleen Cells* 
Age of DBA/2  Frequency of Ig  ÷ 
donor  cells 
Net percent cytotoxicity$ 
Unsorted  Ig-  Ig  + 
14 days  16.1  5.7  2.7  20.6 
21 days  54.1  18.3  2.8  31.4 
35 days  57.1  31.4  9.6  73.9 
Adult  59.2  34.5  7.2  66.7 
* Cytotoxicity was measured by the trypan blue dye exclusion technique. 
The maximum percent cytotoxicity caused by a dilution (1:2-1:32) of the absorbed C57BL/6 anti- 
DBA/2 antiserum minus the maximum percent cytotoxicity caused by a  dilution (1:2-1:32) of 
NMS. Cells were labeled with F1 anti-Ig and passed through the FACS before treatment with the 
absorbed antisera. Ig  + Ig  cells were separated using the FACS. 
have a deficiency in a subpopulation of B lymphocytes. This subpopulation of 
cells develops late  in  neonatal  life  and  can be  distinguished from other B 
lymphocytes by the presence of the following surface membrane characteristics: 
(a) the complement receptor (14), (b) the minor lymphocyte stimulating (Mls) 
coded lymphocyte-activating  determinants (LADs) (12-17), (c) a low density of 
IgM (2), (d) a low-to-intermediate density of total Ig (2), and (e) a relatively low 
ratio of surface IgM to IgD  (9). The apparent absence of this  B-lymphocyte 
subpopulation in CBA/N mice presented an opportunity to develop an antiserum 
directed against differentiation antigens unique to these cells (2, 9-12). Initially 
both CBA/N anti-CBA/J,  and (CBA/N  9  x  DBA/2  ~)F, male anti-F, female 
sera were prepared.  Unfortunately, both these antisera were not  cytotoxic. 
Therefore, we adopted the strategy of producing a polyvalent antiserum and 
rendering it specific for the B-lymphocyte alloantigen by extensive absorption 
with thymus and spleen cells from immune defective mice. Thus, C57BL/6 mice 
were immunized with DBA/2 spleen cells and the resulting serum absorbed with 
thymus and  spleen  cells  from  (CBA/N  ~  x  DBA/2  d)F,  male mice.  This 
absorbed serum lysed fewer than 6% F, male spleen cells, but was cytotoxic for 
25-35% of DBA/2 F, female spleen cells. The small percent of F, male spleen cells 
lysed by the absorbed antisera may reflect the existence of a small number of 
alloantigen-bearing B lymphocytes in the immune defective mice. More likely, 
it reflects the presence of antisera against DBA/2 histecompatibility antigens, 
which were not completely removed during the absorption procedure. 
Analysis of the lysis of normal lymphoid cells by the absorbed antiserum 
showed that approximately 50-70% of Ig  ÷ adult F, female or DBA/2 spleen cells 
were susceptible to lysis, but that only 20% of Ig  + spleen cells of immature mice 
(14-day-old  DBA/2)  were lysed. Therefore, the determinants detected by the 
absorbed antiserum were found on a late developing B-lymphocyte subpopula- 
tion. This is what was predicted before the testing of the antiserum, knowing 
the cell type which was absent from the populations of immune defective cells 
used for absorption. Furthermore, the Ig  + cells which are killed by the absorbed 
antiserum have a relatively low density of surface Ig, a low ratio of surface IgM 
to IgD, and a large percentage of them bear the CR. These are characteristics 
that distinguish mature (or late developing) B-lymphocyte subpopulations from 
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These findings indicate that there is an allotypic differentiation antigen (or 
antigens)  on  a  subpopulation  of B  lymphocytes which can be  identified by 
making use of a  mouse strain which has a  defect in the development of this 
population. Strain distribution analyses are underway to further characterize 
this  new  allotypic antigen.  Preliminary experiments  using anti-Ly 4.1  sera 
indicate that such sera lyse all of the Ig  + cells derived from both (CBA/N  Q x 
DBA/2  c~)F~ male and female mice  (Ahmed,  A.,  I.  Scher,  and W.  E.  Paul. 
Unpublished observations). Thus, the alloantigen reported in this communica- 
tion must be distinct from Ly 4.1.  Tentatively, we propose to designate this B- 
cell differentiation antigen as Lyb 5.1. 
Summary 
CBA/N mice  and F~  male mice,  which are  hemizygous for the  CBA/N  X 
chromosome,  have  an  immune  defect which  is  associated with the  absence 
(deficiency) of a subpopulation of  mature or late developing B lymphocytes. This 
characteristic was utilized to develop an antiserum that was specific for this 
subclass of B cells. C57BL/6 mice were immunized with DBA/2 spleen cells, and 
the resulting antisera was absorbed with lymphoid cells derived from immuno- 
logically abnormal (CBA/N Q x  DBA/2 d)Fl male mice. The absorbed antisera 
was cytotoxic for a subpopulation of lymphocytes  that was present in the spleens 
of adult DBA/2 and (CBA/N  Q x  DBA/2  d)F~ female mice. 
The cells killed by the absorbed antisera were Ig-bearing, complement recep- 
tor-bearing B  lymphocytes, which had  a  low-to-intermediate density of total 
surface Ig. Moreover, the cells remaining after treatment of adult (CBA/N 2  x 
DBA/2  d)Fl female spleen cells with the absorbed antisera and C had a  high 
ratio of surface IgM to  IgD.  The  development of this cytotoxic alloantisera, 
which is specific for a late developing (mature) subpopulation of B lymphocytes, 
will allow the functional characterization of subclasses of B lymphocytes. 
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